Clinical Trials Browser

Phase 1/2 × Osteosarcoma × Etoposide × Clear all

NCT02432274 2023-07-11

Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adults With Osteosarcoma

Phase 1/2 Completed

117 enrolled 32 charts

Neoplasms, Osteosarcoma

NCT05590572 2022-10-21

A Study of Sulfatinib on Relapsed or Refractory Drug Resistant Osteosarcoma

Phase 1/2 Not yet recruiting

Osteosarcoma